Association of interferon-γ +874A polymorphism with reduced long-term inflammatory response in haemodialysis patients

Nephrology Dialysis Transplantation

Volumn 21, Issue 5, 2006, Pages 1317-1322

  Biolo, Gianni ^a   Amoroso, Antonio ^a   Savoldi, Silvana ^b   Bosutti, Alessandra ^a   Martone, Massimiliano ^b   Pirulli, Doroti ^b   Bianco, Francesco ^b   Ulivi, Sheila ^a   Bertok, Sara ^a   Artero, Mary ^b   Barazzoni, Rocco ^a   Zanetti, Michela ^a   Grassi, Gabriele ^a   Guarnieri, Gianfranco ^a   Panzetta, Giovanni ^b  

^a UNIVERSITY OF TRIESTE   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

Author keywords

C reactive protein; Chronic renal failure; Haemodialysis; Inflammation; Interferon gamma; Polymorphisms

Indexed keywords

ADENINE; C REACTIVE PROTEIN; GAMMA INTERFERON; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INTERLEUKIN 10; INTERLEUKIN 6; MESSENGER RNA; THYMINE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ALLELE; ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FOLLOW UP; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INFLAMMATION; INTRON; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL RATE;

AGED; ALLELES; C-REACTIVE PROTEIN; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION; GENETIC MARKERS; HUMANS; INFLAMMATION MEDIATORS; INTERFERON TYPE II; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROBABILITY; PROGNOSIS; RENAL DIALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 33646196729     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfk033     Document Type: Article

References (20)

1. Kalantar-Zadeh K, Ikizler TA, Block G, Avram MM, Kopple JD. Malnutrition-inflammation complex syndrome in dialysis patients: Causes and consequences. Am J Kidney Dis 2003; 42: 864-881
2. Stenvinkel P, Ketteler M, Johnson RJ et al. IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia - the good, the bad, and the ugly. Kidney Int 2005; 67: 1216-1233
3. Tsirpanlis G, Bagos P, Ioannou D et al. The variability and accurate assessment of microinflammation in haemodialysis patients. Nephrol Dial Transplant 2004; 19: 150-157
4. Billiau A. Interferon γ: Biology and role in pathogenesis. Adv Immunol 1996; 62: 61-130
5. Rossouw M, Nel HJ, Cooke GS, van Helden PD, Hoal EG. Association between tuberculosis and a polymorphic NFkappaB binding site in the interferon γ gene. Lancet 2003; 361: 1871-1872
6. Warle MC, Farhan A, Metselaar HJ et al. Are cytokine gene polymorphisms related to in vitro cytokine production profiles? Liver Transpl 2003; 9: 170-181
7. Girndt M, Sester U, Sester M et al. The interleukin-10 promoter genotype determines clinical immune function in hemodialysis patients. Kidney Int 2001; 60: 2385-2391
8. Vickers MA, Green FR, Terry C et al. Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein. Cardiovasc Res 2002; 53: 1029-1034
9. Vatay A, Bene L, Kovacs A et al. Relationship between the tumor necrosis factorα polymorphism and the serum C-reactive protein levels in inflammatory bowel disease. Immunogenetics 2003; 55: 247-252
10. Balakrishnan VS, Guo D, Rao M et al. HEMO Study Group. Cytokine gene polymorphisms in hemodialysis patients: Association with comorbidity, functionality, and serum albumin. Kidney Int 2004; 65: 1449-1460
11. Girnd M, Kaul H, Sester U et al. Anti-inflammatory interleukin-10 genotype protects dialysis patients from cardiovascular events. Kidney Int 2002; 62: 949-955
12. Pravica V, Perrey C, Stevens A, Lee JH, Hutchinson IV. A single nucleotide polymorphism in the first intron of the human IFN-γ gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-γ production. Hum Immunol 2000; 61: 863-866
13. Amoroso A, Pirulli D, Florian F et al. AGXT gene mutations and their influence on clinical heterogeneity of type 1 primary hyperoxaluria. J Am Soc Nephrol 2001; 12: 2072-2079
14. Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 1993; 15: 532-534, 536-537
15. Biolo G, Iscra F, Bosutti A et al. Growth hormone decreases muscle glutamine production and stimulates protein synthesis in hypercatabolic patients. Am J Physiol Endocrinol Metab 2000; 279: E323-E332
16. Lagrand WK, Visser CA, Hermens WT et al. C-Reactive protein as a cardiovascular risk factor. More than an epiphenomenon? Circulation 1999; 100: 96-102
17. Gunnell J, Yeun JY, Depner TA, Kaysen GA. Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis 1999; 33: 63-72
18. Striz I, Mio T, Adachi Y, Carnevali S, Romberger DJ, Rennard SI. Effects of interferons α and γ on cytokine production and phenotypic pattern of human bronchial epithelial cells. Int J Immunopharmacol 2000; 22: 573-585
19. Nakagomi A, Freedman SB, Geczy CL. Interferon γ and lipopolysaccharide potentiate monocyte tissue factor induction by C-reactive protein: relationship with age, sex, and hormone replacement treatment. Circulation 2000; 101: 1785-1791
20. Perianayagam MC, Jaber BL, Guo D, King AJ, Pereira BJ, Balakrishnan VS. Defective interleukin-10 synthesis by peripheral blood mononuclear cells among hemodialysis patients. Blood Purif 2002; 20: 543-550